Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US Senator Calls Out Big Pharma Over Improper Inhaler Patents
AstraZeneca, Boehringer Ingelheim, GSK And Teva Urged To Remove Patents From Orange Book
Feb 01 2024
•
By
Urtė Fultinavičiūtė
The FTC challenged over 100 patents last year • Source: Shutterstock
More from Legal & IP
More from Generics Bulletin